Exogenous netrin-1 enhanced glioma cell proliferation in a dose-dependent manner, and the most effective concentrations were 40–60 ng/ml for U251 cells, 20–60 ng/ml for U87MG cells, and 10–80 ng/ml for SHG44 cells. Here, NTN1 is linked to glioma.